Saxonov Serge's Form 4 filing
10x Genomics, Inc. (TXG) · filed Dec 9, 2021
- Accession no.
- 0001567619-21-021857
- Filed
- Dec 9, 2021
- Trade date
- Dec 7, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.19M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saxonov SergeCIK 0001786720 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 | Class A Common Stock | MOption exerciseAcquired | +5,209 | $5.04 | +$26,253.36 | 889,818 | Direct | |
| Dec 7, 2021 | Class A Common Stock | MOption exerciseAcquired | +3,037 | $11.48 | +$34,864.76 | 892,855 | Direct | |
| Dec 7, 2021 | Class A Common Stock | SSaleDisposed | −200 | $138.86 | −$27,772 | 892,655 | Direct | |
| Dec 7, 2021 | Class A Common Stock | SSaleDisposed | −766 | $142.40F2 | −$109,078.4 | 891,889 | Direct | |
| Dec 7, 2021 | Class A Common Stock | SSaleDisposed | −3,187 | $143.36F3 | −$456,888.32 | 888,702 | Direct | |
| Dec 7, 2021 | Class A Common Stock | SSaleDisposed | −672 | $144.27F4 | −$96,949.44 | 888,030 | Direct | |
| Dec 7, 2021 | Class A Common Stock | SSaleDisposed | −571 | $145.79F5 | −$83,246.09 | 887,459 | Direct | |
| Dec 7, 2021 | Class A Common Stock | SSaleDisposed | −6,480 | $147.05F6 | −$952,884 | 880,979 | Direct | |
| Dec 7, 2021 | Class A Common Stock | SSaleDisposed | −2,370 | $147.96F7 | −$350,665.2 | 878,609 | Direct | |
| Dec 7, 2021 | Class A Common Stock | SSaleDisposed | −754 | $148.60F8 | −$112,044.4 | 877,855 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 | Class A Common Stock | MOption exerciseDisposed | −5,209 | $0.00 | $0 | 53,323 | Direct | |
| Dec 7, 2021 | Class A Common Stock | MOption exerciseDisposed | −3,037 | $0.00 | $0 | 48,596 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $141.77 to $142.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $142.86 to $143.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $144.00 to $144.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $145.34 to $146.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $146.45 to $147.42. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $147.4621 to $148.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $148.545 to $148.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.